How many studies have been conducted on Enviomycin?

BiohacksAI has indexed 38 PubMed studies on Enviomycin. 29% of studies involve human subjects.

What are the main research areas for Enviomycin?

The primary research domains for Enviomycin are 🫁 Respiratory, 🧠 Focus & Attention, 😴 Sleep. This is based on analysis of 38 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Enviomycin

an induced mutant of Streptomyces griseoverticillatus var. tuberacticus and acts as an antitubercular agent with less ototoxicity than tuberactinomycin.

38+ PubMed studies analyzed · Evidence Score: 37.8

Research Domains

Enviomycin has been studied across 5 research domains including 🫁 Respiratory, 🧠 Focus & Attention, 😴 Sleep, ✨ Skin & Hair, 👁️ Vision & Eye. The primary research focus is 🫁 Respiratory with 40% of studies addressing this area.

Loading evidence profile...

This evidence profile for Enviomycin is generated deterministically from 38 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.